seed
Stage
2
Investors
About
Xylo develops targeted neurotherapeutics designed to enhance neuroplasticity and restore brain function for neurological and psychiatric disorders using advanced neuroscience and computational drug discovery.
Explore Xylo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.